GlassScriptPhysician profile
John R Northrup
NPI 1891178406
$12,431.09
in general payments reported to CMS, 2019-2025
29 companies · $3,294 in 2025
The $3,294 reported for 2025 was more than what 90% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,125 · 2020: $358 · 2021: $2,767 · 2022: $1,520 · 2023: $1,231 · 2024: $1,137 · 2025: $3,294.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,498 · Travel and Lodging: $2,163.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,498.31 |
| Travel and Lodging | $2,163.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragon 28, INC. | $2,817.45 | 2021-2025 | Apex 3d, Mtp, Hammertube Sterile Implant Kits |
| Stryker Corporation | $2,389.05 | 2021-2025 | Salvation, Prostep, Prophecy |
| Smith+Nephew, INC. | $2,171.27 | 2019-2025 | Collagenase Santyl, Grafix, Pico |
| Wright Medical Technology, INC. | $1,578.63 | 2019-2020 | |
| Arthrex, INC. | $696.40 | 2025 | |
| Kerecis Limited | $370.25 | 2019-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Sanara Medtech INC. | $322.90 | 2021-2022 | |
| Horizon Therapeutics Plc | $251.56 | 2019-2023 | Krystexxa |
| Organogenesis INC. | $250.54 | 2019-2024 | Affinity, Apligraf, Puraply Wound Matrix |
| Integra Lifesciences Corporation | $246.46 | 2020-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Cardiovascular Systems INC. | $172.02 | 2022 | |
| Acera Surgical, INC. | $171.35 | 2022-2025 | Restrata Wound Matrix |
| Orthofix Medical, INC. | $159.15 | 2024-2025 | Truelok |
| Derma Sciences, INC. | $132.41 | 2019 | |
| Team 1, LLC | $123.55 | 2023-2025 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Access Pro Medical, LLC | $121.03 | 2025 | Matriderm |
| Averitas Pharma INC. | $92.62 | 2025 | Qutenza |
| Osiris Therapeutics INC. | $63.79 | 2019 | |
| Paratek Pharmaceuticals, INC. | $53.23 | 2024-2025 | Nuzyra |
| Amgen INC. | $40.50 | 2024-2025 | Krystexxa |
| Misonix INC | $37.49 | 2020 | |
| Biotissue Holdings INC. | $31.48 | 2024 | |
| Crossroads Extremity Systems, LLC | $27.12 | 2019 | |
| Ermi LLC | $22.04 | 2021 | |
| Treace Medical Concepts, INC. | $21.79 | 2025 | |
| Curonix LLC | $19.70 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Trice Medical, INC. | $18.65 | 2022 | |
| Alfasigma USA, INC. | $16.50 | 2020 | |
| Advanced Oxygen Therapy INC. | $12.16 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Northrup listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.